Buserelin for Rabbits: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Buserelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist. In plain language, it acts like the rabbit's natural reproductive signaling hormone and stimulates release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. That hormone surge can help trigger ovulation at a more predictable time.

In rabbits, buserelin is used far more often in reproductive management than in routine pet medicine. Rabbits are induced ovulators, which means ovulation usually happens after mating or another stimulus. Because of that biology, your vet may use buserelin in selected breeding situations to help coordinate ovulation with mating or artificial insemination.

This medication is not a routine at-home fertility supplement and it is not a substitute for diagnosing the reason a rabbit is not conceiving. If a pet rabbit has vaginal discharge, reduced appetite, abdominal enlargement, or bleeding, your vet will usually need to rule out uterine disease first. In older intact female rabbits, uterine disease and uterine adenocarcinoma are important concerns, and surgery may be more appropriate than hormone treatment in many cases.

In rabbits, buserelin is mainly used to induce ovulation and to support timed breeding programs, especially around artificial insemination. Published rabbit studies and veterinary product labeling describe use at the time of insemination or mating, and one licensed veterinary product lists use for postpartum ovulation induction and for improving conception rate in does.

For pet parents, that means buserelin is usually relevant only when your vet is helping manage a breeding doe or a specialized reproductive case. It is not commonly used as a general treatment for vague signs like nesting behavior, mood changes, or false pregnancy without a clear reproductive plan.

It is also important to keep expectations realistic. If an intact female rabbit is having reproductive signs but is not intended for breeding, your vet may recommend other options first. Spaying is often the more practical treatment for many uterine and ovarian problems in pet rabbits, especially because intact females over 3 years old have a high risk of reproductive tract disease.

Buserelin dosing in rabbits should be set only by your vet, because the correct dose depends on the product concentration, the route used, and the treatment goal. A current veterinary product label for rabbits lists 0.00084 mg (0.84 micrograms) per rabbit, given by intramuscular injection, for ovulation induction postpartum or to improve conception rate at the time of insemination or mating.

Published rabbit reproduction studies have also used 0.8 micrograms per doe intramuscularly at artificial insemination, with higher intravaginal doses of 8 to 16 micrograms per doe when the drug was added to the insemination dose. Those are research and breeding-protocol doses, not general home-use instructions.

Because buserelin is a potent hormone medication, small measuring errors matter. Your vet may choose injection over other routes because rabbits need precise dosing and careful handling. Do not substitute human fertility products, nasal sprays, or compounded hormone products unless your vet specifically instructs you to do so.

If a dose is missed in a timed breeding plan, call your vet promptly. With reproductive drugs, timing can be as important as the dose itself.

Buserelin appears to have low acute toxicity in veterinary labeling, and overdose is described as unlikely to cause intoxication at typical clinical exposures. Still, that does not mean every rabbit tolerates it the same way. Rabbits can hide illness well, so even mild changes deserve attention.

After treatment, monitor for reduced appetite, fewer fecal pellets, lethargy, stress, or discomfort at the injection site. In rabbits, any medication-related stress can contribute to gastrointestinal slowdown, which is one reason close observation matters. If your rabbit stops eating, seems painful, or produces very small or no droppings, see your vet right away.

Because buserelin affects reproductive hormones, your vet may also discuss expected reproductive changes tied to the treatment goal, such as induced ovulation. In breeding rabbits, the bigger practical concern is often not a dramatic drug reaction but whether the medication was used in the right patient, at the right time, and for the right reason.

See your vet immediately if your rabbit develops weakness, collapse, persistent anorexia, abdominal swelling, vaginal bleeding, or signs of GI stasis after any hormone treatment.

Published rabbit-specific interaction data for buserelin are limited, so your vet will usually review the whole reproductive plan rather than looking for one classic interaction list. The main concern is how buserelin fits with other hormones or fertility drugs that affect ovulation timing, uterine function, or conception rate.

Tell your vet about any recent or planned use of other reproductive hormones, including prostaglandins, hCG, progesterone-type drugs, or compounded fertility medications. Combining hormone therapies without a clear protocol can make timing harder to interpret and may reduce the value of the treatment cycle.

Also mention all supportive medications, supplements, and recent procedures. In rabbits, the practical risk is often indirect: stress, transport, sedation, pain, or underlying uterine disease can interfere with eating, recovery, and breeding success even if they do not create a classic drug-drug interaction.

If your rabbit is a pet rather than part of a breeding program, ask your vet whether a hormone medication is truly the best fit. In many intact female rabbits with reproductive signs, diagnostics or spay surgery may offer a clearer path than repeated hormone use.